StockWatch
·
Pharmaceuticals
Board Meeting5 Nov 2026, 12:02 pm

Oxygenta Pharmaceutical Board Meeting on Nov 10, 2026

AI Summary

Oxygenta Pharmaceutical Ltd has announced that its Board of Directors will convene on November 10, 2026. The meeting agenda includes the consideration and approval of the un-audited financial results for the quarter and half-year ended September 30, 2026, along with the Limited Review Report for the same period. The meeting will be held at the company's corporate office.

Key Highlights

  • Board meeting scheduled for November 10, 2026.
  • Agenda includes un-audited financial results.
  • Review of financial results for Q2 FY27 and H1 FY27.
  • Limited Review Report for the quarter will be considered.